ARTICLE | Clinical News
Digene regulatory update
October 19, 1998 7:00 AM UTC
The FDA granted 510(k) marketing clearance for DIGE's Hybrid Capture CMV DNA test to diagnose CMV infection in transplant and AIDS patients. DIGE's Hybrid Capture technology uses RNA probes to bind s...